Literature DB >> 18665380

Tubal ectopic pregnancy: diagnosis and management.

Vivek Nama1, Isaac Manyonda.   

Abstract

Ectopic pregnancy is the gynaecological emergency par excellence and remains the leading cause of pregnancy-related first trimester deaths in the UK. Its prevalence continues to rise because of increases in the incidence of the risk factors predisposing to ectopic pregnancy. Classically, the diagnosis is based on a history of pelvic pain associated with amenorrhoea, a positive pregnancy test with or without slight vaginal bleeding. While the immediate differential diagnosis includes threatened or inevitable miscarriage, the likelihood of ectopic pregnancy is increased if transvaginal sonography (TVS) reveals an empty uterine cavity, and is confirmed if an adnexal mass with or without an embryo is seen. However, the diagnosis is often not that simple, especially when the patient presents early, has minimal pain, is haemodynamically stable, and TVS shows an empty uterus but no obvious adnexal mass. This could then be an early intrauterine pregnancy, or could indeed be an ectopic-a diagnosis of pregnancy of unknown location is made while additional investigations are made. The latter usually include serial measurements of serum beta human chorionic gonadotrophin (beta-hCG) and repeat TVS. Changes in beta-hCG levels in normal, failing and ectopic pregnancy are now reasonably well characterised, and at early stages of presentation where the risk of rupture of an ectopic are minimal, the patient can often be managed as an outpatient while the diagnosis is pursued. In the patient who presents with pain and haemodynamic instability, the diagnosis is often obvious, and the management is immediate laparotomy. However, in modern gynaecological practice in the developed world the vast majority of ectopic pregnancies present early, and the general consensus is that laparoscopic management offers both economic and aesthetic advantages, and should be used whenever possible. Salpingectomy (excision of the fallopian tube containing the ectopic) is performed if the contra-lateral tube is healthy, while salpingotomy (linear incision made in the fallopian tube with removal of ectopic pregnancy and conservation of tube) is performed if the contra-lateral tube is unhealthy. Medical therapy using methotrexate given systemically or injected directly into the ectopic pregnancy is an option occasionally used with good results. There appear to be no major differences in subsequent fertility outcomes, or risk of recurrence of ectopic pregnancy, between the surgical or medical treatments. Although the rates of ectopic pregnancy are not falling in the developed world, mortality and morbidity are falling mainly due to early and improving diagnostic and treatment modalities. Mass screening and treatment of Chlamydia in the young, sexually active populations, and education regarding risk factors, may in future result in a reduction in the rates. Lack of resource mean that the picture may remain dismal for some time to come in the developing world, but the development of basic protocols, improved training and the infusion of basic resources may go a long way to improving the situation.

Entities:  

Mesh:

Year:  2008        PMID: 18665380     DOI: 10.1007/s00404-008-0731-3

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  19 in total

1.  Diagnosis of emergencies/urgencies in gynecology and during the first trimester of pregnancy.

Authors:  Stefano Zucchini; Elena Marra
Journal:  J Ultrasound       Date:  2014-01-09

2.  Increased expression of the von Hippel-Lindau gene in the implantation site of human tubal pregnancy.

Authors:  Jian-Ying Xu; Wei-Jie Zhu; Huan Jiang
Journal:  Mol Cell Biochem       Date:  2012-06-20       Impact factor: 3.396

Review 3.  The need for serum biomarker development for diagnosing and excluding tubal ectopic pregnancy.

Authors:  Andrew W Horne; W Colin Duncan; Hilary Od Critchley
Journal:  Acta Obstet Gynecol Scand       Date:  2010-03       Impact factor: 3.636

4.  Bilateral ectopic pregnancy following ICSI.

Authors:  Mehtap Polat; Fazilet Kübra Boynukalın; İrem Yaralı; Hakan Yaralı
Journal:  BMJ Case Rep       Date:  2014-06-26

5.  Diagnosis and management of ectopic pregnancy.

Authors:  Vanitha N Sivalingam; W Colin Duncan; Emma Kirk; Lucy A Shephard; Andrew W Horne
Journal:  J Fam Plann Reprod Health Care       Date:  2011-07-04

6.  Participation of the oviductal s100 calcium binding protein G in the genomic effect of estradiol that accelerates oviductal embryo transport in mated rats.

Authors:  Mariana Ríos; Alexis Parada-Bustamante; Luis A Velásquez; Horacio B Croxatto; Pedro A Orihuela
Journal:  Reprod Biol Endocrinol       Date:  2011-05-23       Impact factor: 5.211

7.  Differential use of diagnostic ultrasound in u.s. Emergency departments by time of day.

Authors:  John C Stein; Vanessa L Jacoby; Eric Vittinghoff; Ralph Wang; Elizabeth Kwan; Teri Reynolds; Ian McAlpine; Ralph Gonzales
Journal:  West J Emerg Med       Date:  2011-02

8.  Fertility outcome analysis after surgical management of tubal ectopic pregnancy: a retrospective cohort study.

Authors:  Jingwei Li; Kailei Jiang; Fujie Zhao
Journal:  BMJ Open       Date:  2015-09-08       Impact factor: 2.692

9.  Can ratio of blood/curettage material HCG be used as a reliable method for differentiating miscarriage and ectopic pregnancy?

Authors:  Gokhan Acmaz; Huseyin Aksoy; Evrim Bayraktar; Muruvvet Baser; Gokmen Zararsiz; Iptisam Ipek Muderris
Journal:  Pak J Med Sci       Date:  2013-09       Impact factor: 1.088

10.  Awareness about a life-threatening condition: ectopic pregnancy in a network for surveillance of severe maternal morbidity in Brazil.

Authors:  Edilberto Alves Rocha Filho; Danielly Scaranello Santana; Jose Guilherme Cecatti; Maria Laura Costa; Samira Maerrawe Haddad; Mary Angela Parpinelli; Maria Helena Sousa; Rodrigo Soares Camargo; Rodolfo Carvalho Pacagnella; Fernanda Garanhani Surita; Joao Luiz Pinto e Silva
Journal:  Biomed Res Int       Date:  2014-03-19       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.